Overview
Watchlist
Equities
Crypto
Soon
Popular
Cookies
Terms of Service
Privacy Policy
Home
© 2025 FYStats 
Home
Equities
GRCE
Chart

Grace Therapeutics, Inc.

GRCE

Jan 1 1970 00:00:00
3.38
▲0.1500▲4.65%
3.24
3.38
3.24
3.23
251.00
-0.79
-4.27
46.67M
13.83M
Chart
Fundamentals
Soon
Sentiment
Soon
Options
Loading...

Recent Filings

2024-10-28
Form 8-K
ID: 0001140361-24-044363
2024-10-25
Form 8-K
ID: 0001140361-24-044212
2024-10-15
EFFECT
ID: 9999999995-24-003181
2024-10-15
EFFECT
ID: 9999999995-24-003184
2024-10-08
Form S-8
ID: 0001140361-24-043046
2024-10-08
Form S-8 POS
ID: 0001140361-24-043044
2024-10-08
Form S-8 POS
ID: 0001140361-24-043043
2024-10-08
Form S-8 POS
ID: 0001140361-24-043042
2024-10-08
Form POS AM
ID: 0001140361-24-043041
2024-10-08
Form POS AM
ID: 0001140361-24-043036

You might find these companies interesting

SMMT
Summit Therapeutics Inc.
Pharmaceutical Preparations (2834)
GNPX
Genprex, Inc.
Pharmaceutical Preparations (2834)
ALZN
Alzamend Neuro, Inc.
Pharmaceutical Preparations (2834)
HEPA
Hepion Pharmaceuticals, Inc.
Pharmaceutical Preparations (2834)
PHIO
Phio Pharmaceuticals Corp.
Pharmaceutical Preparations (2834)
NRBO
Neurobo Pharmaceuticals, Inc.
Pharmaceutical Preparations (2834)
BETRF
Betterlife Pharma Inc.
Pharmaceutical Preparations (2834)
SYRE
Spyre Therapeutics, Inc.
Pharmaceutical Preparations (2834)
KPTI
Karyopharm Therapeutics Inc.
Pharmaceutical Preparations (2834)
QLI
Qilian International Holding Group Ltd
Pharmaceutical Preparations (2834)
SNNC
Sibannac, Inc.
Pharmaceutical Preparations (2834)
NRSN
Neurosense Therapeutics Ltd.
Pharmaceutical Preparations (2834)
SRNE
Sorrento Therapeutics, Inc.
Biological Products, (No Diagnostic Substances) (2836)
NAVB
Navidea Biopharmaceuticals, Inc.
In Vitro & In Vivo Diagnostic Substances (2835)